Analysis of efficacy and safety of drotrecogin alfa (activated) in surgical patients, using an international integrated database.
de Pont
Anne-Cornélie J M
AC
Bakx
Roel
R
Boermeester
Marja A
MA
Schultz
Marcus J
MJ
D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D016208:Databases, Factual; D006801:Humans; D011486:Protein C / Q000009:adverse effects* / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D018570:Risk Assessment; D018805:Sepsis / Q000188:drug therapy* / Q000209:etiology; D013514:Surgical Procedures, Operative / Q000009:adverse effects*; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated